Live Webinar

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Hosted by AJMC and Targeted Oncology

-- Days : -- HRS : -- MIN : -- SEC
Register Now →
Logo Image
News|Articles|March 6, 2026

AJMC® in the Press, March 6, 2026

Listen
0:00 / 0:00

Key Takeaways

  • Coverage denials and prior authorization delays can compromise timely treatment, creating clinical deterioration and compounding financial toxicity as care escalates.
  • Broadened semaglutide eligibility signals substantial demand, while payer coverage limitations and drug pricing remain central constraints on real-world uptake.
SHOW MORE

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article from the Sparta Independent referenced a feature published on AJMC.com, the website of The American Journal of Managed Care® (AJMC®). The article, “How Insurance Claim Denials Harm Patients’ Health, Finances,” focused on how delays in receiving coverage for essential medication, including through insurance claim denials, can hinder treating patients, especially as symptoms worsen and costs increase.

An AJMC.com article titled “Semaglutide Eligibility Expands to Over Half of US Adults” was referenced in an article from The Healthy. The former highlighted semaglutide’s potential benefits in the US for weight loss and diabetes, though access and cost concerns were prevalent.

An article from Healthandme referenced a Q&A published on AJMC.com. The Q&A, “3 Pillars of CRC Prevention Can Curb Rising Mortality: Jordan Karlitz, MD,” featured Karlitz discussing how younger patients could identify symptoms before more issues could occur, especially as the incidence of colorectal cancer rises in younger populations.

An article from AJMC.com, “Autism Research Leaders Launch Independent Committee to Counter RFK’s Panel,” was referenced in an article by Tag24. The AJMC.com piece discussed the formation of an independent coordinating body formed of leading autism researchers and advocates that is aiming to counter recent changes to the Interagency Autism Coordinating Committee overseen by HHS.

Related Content